Benchmark your payer engagement team's performance against the industry's best! Winning payer support to secure reimbursement and optimum pricing is a battle payer engagement teams' face daily. But in the face of ever...

Ensuring payer support, delivering stakeholder benefit and generating commercial returns: Pharma's growing orphan drug challenge Rising competition and closer scrutiny by hard-pressed payers are just two of the trends...

Payer Attitudes to Orphan Drug Funding The explosion of orphan drugs across Europe and the US is pushing healthcare finances towards breaking point according to payers. Requests for orphan drug designation have reached...

Orphan drug market access and pricing: strategies for success When it comes to securing market access and drug pricing for orphan drugs, a one size approach won’t work. Driven by increasing competition and cost...

Orphan Drugs: Future opportunities and challenges   The orphan drug sector is booming. Record product approvals, robust pipelines and regulatory incentives. But will the good times last? As the market matures...

Why is the patient voice critical to orphan drug success? Patient input is critical to an orphan drug’s success, but how and when should you engage and what trends and drivers are shaping their involvement?...